← Back to Clinical Trials
Recruiting NCT04087031

NCT04087031 Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04087031
Status Recruiting
Phase
Sponsor Istituto Nazionale di Ricovero e Cura per Anziani
Condition Parkinson Disease
Study Type INTERVENTIONAL
Enrollment 195 participants
Start Date 2019-12-03
Primary Completion 2026-12-31

Trial Parameters

Condition Parkinson Disease
Sponsor Istituto Nazionale di Ricovero e Cura per Anziani
Study Type INTERVENTIONAL
Phase N/A
Enrollment 195
Sex ALL
Min Age 65 Years
Max Age N/A
Start Date 2019-12-03
Completion 2026-12-31
Interventions
control armvirtual reality gamesrobotic treadmill

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The final goal of the present study is to propose a new approach in the Parkinson's Disease rehabilitation, focused on the use of robotic devices and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.

Eligibility Criteria

Inclusion Criteria: * Hoen and Yahr scale: 1-3 stage * FAC ≤ 2 * Ranking scale score ≤ 3 * Stability of drug treatment for at least 1 month * Geriatric Depression Scale 5-items: negative Exclusion Criteria: * Concomitant participation in other studies * Lack of written informed consent * Clinical dementia rating (CDR) score ≥ 3 * History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically * Serious dysfunction of the autonomic system * Severe behavioral syndromes not compensated by drugs * Concurrent neurological diseases * Severe systemic diseases with life expectancy \< 1 year * Patients unable to follow up.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology